NEW YORK (Reuters Health) – The bone anabolic drug teriparatide is more effective than alendronate at increasing bone mineral density (BMD) and preventing vertebral fractures in patients with…
NEW YORK (Reuters Health) – In kidney transplant recipients, bringing hemoglobin levels above 125 g/L with erythropoietin may increase mortality, according to a report in the November 6th…
NEW YORK (Reuters Health) – Monofilament testing alone is inadequate for diagnosing peripheral neuropathy, according to a systematic literature review done by physicians in The Netherlands. As the…
NEW YORK (Reuters Health) – Exercise-induced ST-segment elevation in patients who never had a myocardial infarction (MI) is a highly specific marker of coronary artery disease and a…
NEW YORK (Reuters Health) – More than half of women in a recent survey had undiagnosed urinary incontinence, with two thirds reporting moderate to severe symptoms. Because urinary…
NEW YORK (Reuters Health) – Blood transfusion is safe and may be beneficial in patients with acute decompensated heart failure, say researchers from Israel in the October American…
NEW YORK (Reuters Health) – MRI of the breast has the greatest potential, compared with digital mammography or whole-breast ultrasound, for detecting cancers missed by film screen mammogram,…
Hugh S. Taylor, MD, is Professor of Obstetrics, Gynecology and Reproductive Sciences, and Director of Reproductive Endocrinology and Infertility at the Yale University School of Medicine discusses the…
NEW YORK (Reuters Health) – Giving abciximab to high-risk patients with ST-elevation myocardial infarction (STEMI) before transferring them for percutaneous coronary intervention (PCI) reduces 1-year mortality without increasing…
NEW YORK (Reuters Health) – In women treated for small (1 cm or less), node-negative breast cancers, HER2 positivity is strongly linked to recurrence and poorer disease-free survival,…
